Fig. 8 Test of YB1 and other strains under serial reductions of oxygen level conditions. Different mutant strains at serial dilutions under decreasing oxygen levels were cultured for24 hours and bacterial growth was observed. Columns:1. SL7207; 2. YB-asd;3. YB1;4. PW;5. EW.
1. Pawelek JM, L.K., Bermudes D., Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res, 1997. 57: p. 4537-44.
2. Guo, Z.L., et al., Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma. J Hematol Oncol, 2015. 8: p. 99.
3. Vaupel, P., Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol, 2004. 14: p. 198-206.
4. Vaupel, P., F. Kallinowski, and P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res., 1989. 49: p. 6449-6465.
5. Bertout, J., S. Patel, and M. Simon, The impact of O2 availability on human cancer. Nat. Rev. Cancer, 2008. 8: p. 967-975.
6. Brown, J. and W. Wilson, Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer, 2004. 4: p. 437-447.
7. Johnson SA, O.M., Wall DM., Draft genome sequence of the tumor-targeting Salmonella enterica serovar Typhimurium strain SL7207. . Genome Announc 2017. 5: p. e01591-16.
8. Forbes, N.S., Munn, L. L., Fukumura, D. & Jain, R. K, Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. . Cancer Res, 2003. 63: p. 5188-5193.
9. Leschner S, W.K., Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, Weiss S., Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One., 2009. 4(8): p. e6692.
10. Loessner H, E.A., Leschner S, Westphal K, Rohde M, Miloud T, Hämmerling G, Neuhaus K, Weiss S, Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol., 2007. 9(6): p. 1529-37.
11. Westphal K, L.S., Jablonska J, Loessner H, Weiss S., Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res., 2008. 68(8): p. 2952-60.
12. Strauch, K., et al., Oxygen regulation in Salmonella typhimurium. J. Bacteriol., 1985. 161: p. 673-680.
13. Mengesha A, D.L., Lambin P, Landuyt W, Chiu RK, Wouters BG, Theys J., Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella. Cancer Biol Ther. , 2006. 5(9): p. 1120-1128.
14. Scott, S., S. Busby, and I. Beacham, Transcriptional co-activation at the ansB promoters: involvement of the activating regions of CRP and FNR when bound in tandem. Mol. Microbiol, 1995. 18: p. 521-531.
16. Galán JE, N.K., Curtiss R 3rd., Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene. , 1990. 94(1): p. 29-35.
17. Boysen, A., Moller-Jensen, J., Kallipolitis, B., Valentin-Hansen, P. & Overgaard, M, Translational regulation of gene expression by an anaerobically induced small non-coding RNA in Escherichia coli. J. J Biol Chem, 2010. 285: p. 10690-10702.
18. Yu B, Y.M., Shi L, Yao Y, Jiang Q, Li X, Tang LH, Zheng BJ, Yuen KY, Smith DK, Song E, Huang JD., Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain. Sci Rep, 2012. 2:436. doi: 10.1038/srep00436. Epub 2012 Jun 1.